Author:
Trentham-Dietz Amy,Sprague Brian L.,Klein Ronald,Klein Barbara E. K.,Cruickshanks Karen J.,Fryback Dennis G.,Hampton John M.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Ries L, Melbert D, Krapcho M et al (2007) SEER Cancer Statistics Review, 1975–2004. National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER web site
2. Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360(9340):1131–1135
3. Goodwin PJ, Black JT, Bordeleau LJ et al (2003) Health-related quality-of-life measurement in randomized clinical trials in breast cancer—taking stock. J Natl Cancer Inst 95(4):263–281
4. Costantino J (2002) The impact of hormonal treatments on quality of life of patients with metastatic breast cancer. Clin Ther 24(Suppl C):C26–42
5. Land SR, Wickerham DL, Costantino JP et al (2006) Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295(23):2742–2751